![Alfred N. Nijkerk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alfred N. Nijkerk
Founder at VenGen BV
Alfred N. Nijkerk active positions
Companies | Position | Start | End |
---|---|---|---|
VenGen BV
![]() VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Founder | 22/07/2001 | - |
Private Equity Investor | 01/07/2001 | - | |
Director of Investments | 01/07/2001 | 22/07/2010 | |
UbiQ Bio BV
![]() UbiQ Bio BV Pharmaceuticals: MajorHealth Technology UbiQ Bio BV specializes in the ubiquitin related reagents, peptides and assays. The firm focuses on pharma companies and academic research labs. The company was founded by by Huib Ovaa and Farid El Oualidin in 2010 and is headquartered in Amsterdam, the Netherlands. | Chief Executive Officer | 25/07/2011 | - |
Career history of Alfred N. Nijkerk
Former positions of Alfred N. Nijkerk
Companies | Position | Start | End |
---|---|---|---|
Lactive BV
![]() Lactive BV Food: Major DiversifiedConsumer Non-Durables Lactive is an innovative food ingredients company that develops technology to produce and isolate specialty proteins from milk. Lactive focuses on a class of proteins naturally present in milk; immunoglobulins. These proteins have the particular bio activity to improve resistance of infants, hospitalized persons and elderly. The company was founded in 2005 by Herman de Boer, Alfred Nijkerk, and Willem Fokkema and is headquartered in Velp, The Netherlands. | Founder | 09/02/2010 | 20/07/2011 |
Corporate Officer/Principal | 01/01/2005 | 09/02/2010 | |
to-BBB technologies BV
![]() to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Founder | - | - |
Photonics Healthcare BV
![]() Photonics Healthcare BV Medical SpecialtiesHealth Technology Photonics Healthcare BV engages in the development of medical devices for monitoring mitochondrial function in to clinical practice. It offers Comet monitor, which allows doctors to optically measure the oxygen in the mitochondria inside a patient's cells. The company was founded by Egbert Gezinus Mik, Michael Münker, and Alfred N. Nijkerk in October 2009 and is headquartered in Utrecht, the Netherlands. | Founder | 01/10/2009 | - |
ViciniVax BV
![]() ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | Chief Executive Officer | 16/04/2009 | - |
Founder | 01/01/2008 | - |
Training of Alfred N. Nijkerk
University of Utrecht | Graduate Degree |
Statistics
International
Netherlands | 8 |
Operational
Founder | 5 |
Chief Executive Officer | 2 |
Director of Investments | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
VenGen BV
![]() VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Finance |
to-BBB technologies BV
![]() to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Lactive BV
![]() Lactive BV Food: Major DiversifiedConsumer Non-Durables Lactive is an innovative food ingredients company that develops technology to produce and isolate specialty proteins from milk. Lactive focuses on a class of proteins naturally present in milk; immunoglobulins. These proteins have the particular bio activity to improve resistance of infants, hospitalized persons and elderly. The company was founded in 2005 by Herman de Boer, Alfred Nijkerk, and Willem Fokkema and is headquartered in Velp, The Netherlands. | Consumer Non-Durables |
ViciniVax BV
![]() ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | Health Technology |
Photonics Healthcare BV
![]() Photonics Healthcare BV Medical SpecialtiesHealth Technology Photonics Healthcare BV engages in the development of medical devices for monitoring mitochondrial function in to clinical practice. It offers Comet monitor, which allows doctors to optically measure the oxygen in the mitochondria inside a patient's cells. The company was founded by Egbert Gezinus Mik, Michael Münker, and Alfred N. Nijkerk in October 2009 and is headquartered in Utrecht, the Netherlands. | Health Technology |
UbiQ Bio BV
![]() UbiQ Bio BV Pharmaceuticals: MajorHealth Technology UbiQ Bio BV specializes in the ubiquitin related reagents, peptides and assays. The firm focuses on pharma companies and academic research labs. The company was founded by by Huib Ovaa and Farid El Oualidin in 2010 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Alfred N. Nijkerk
- Experience